A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice

Neuroscience

Volumn 149, Issue 2, 2007, Pages 286-302

  Arendash, G W ^a,b   Jensen, M T ^a,b   Salem Jr , N ^c   Hussein, N ^c   Cracchiolo, J ^a,b   Dickson, A ^a,b   Leighty, R ^b   Potter, H ^a,d  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

amyloid; DHA; EPA; memory

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIET THERAPY; GENETIC MANIPULATION; GENOTYPE; HIPPOCAMPUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANXIETY; CHROMATOGRAPHY, GAS; COGNITION; COGNITION DISORDERS; DIET; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXPLORATORY BEHAVIOR; FATTY ACIDS, OMEGA-3; HIPPOCAMPUS; HUMANS; MAZE LEARNING; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCULOSKELETAL EQUILIBRIUM; NERVE TISSUE PROTEINS; PRESENILIN-1; PSYCHOMOTOR PERFORMANCE; RECOGNITION (PSYCHOLOGY);

EID: 35348824359     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2007.08.018     Document Type: Article

References (58)

1. Arendash G., Gordon M., Diamond D., Austin L., Hatcher J., Jantzen P., DiCarlo G., Wilcock D., and Morgan D. Behavioral assessment of Alzheimer's transgenic mice following long-term Aβ vaccination: task specificity and correlations between Aβ deposition and spatial memory. DNA Cell Biol 20 (2001) 737-744
2. Arendash G., King D., Gordon M., Morgan D., Hatcher J., Hope C., and Diamond D. Progressive, age-related behavioral impairments in transgenic mice carrying both mutant amyloid precursor protein and presenilin-1 transgenes. Brain Res 891 (2001) 42-53
3. Arendash G., Schleif W., Rezaei-Zadeh K., Jackson E., Zacharia L., Cracchiolo J., Shippy D., and Tan J. Caffeine protects Alzheimer's mice against cognitive impairment and reduces brain beta-amyloid production. Neuroscience 142 (2006) 941-952
4. Bang H., Dyerberg J., and Sinclair H. The composition of the Eskimo food in Northwestern Greenland. Am J Clin Nutr 33 (1980) 2657-2666
5. Barberger-Gateau P., Fabrigoule C., Helmer C., Rouch I., and Dartigues J. Functional impairment in instrumental activities of daily living: An early clinical sign of dementia?. J Am Geriatr Soc 47 (1999) 456-462
6. Barberger-Gateau P., Letenneur L., Deschamps V., Peres K., Dartigues J., and Renaud. Fish, meat, and risk of dementia: Cohort study. Br Med J 325 (2002) 932-933
7. Barceló-Coblijn G., Ho{double acute}gyes E., Kitajka K., Puskàs L., Zvara A., Hackler L., Nyakas C., Penke Z., and Farkas T. Modifications by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc Natl Acad Sci U S A 100 (2003) 11321-11326
8. Boston P., Bennett A., Horrobin D., and Bennett C. Ethyl-EPA in Alzheimer's disease-a pilot study. Prostaglandins Leukot Essent Fatty Acids 71 (2004) 341-346
9. Breslow J. n-3 fatty acids and cardiovascular disease. Am J Clin Nutr 83 (2006) 1477S-1482S
10. Calon F., Lim G., Yang F., Morihara T., Teter B., Ubeda O., Rostaing P., Triller A., Salem N., Ashe K., Frautschy S., and Cole G. Docosahexaenoic acid protects from dendritic pathology in an Alzheimer's disease mouse model. Neuron 43 (2004) 633-645
11. Calon F., Lim G., Morihara T., Yang F., Ubeda O., Salem N., Frautschy S.L., and Cole G. Dietary n-3 polyunsaturated fatty acid depletion activates caspases and decreases NMDA receptors in the brain of a transgenic mouse model of Alzheimer's disease. Eur J Neurosci 22 (2005) 617-626
12. Carrie I., Guesnet P., Bourre J., and Francés H. Diets containing long-chain n-3 polyunsaturated fatty acids affect behaviour differently during development than ageing in mice. Br J Nutr 83 (2000) 439-447
13. Chalon S., Delion-Vancassel S., Belzung C., Guilloteau D., Leguisquet A., Besnard J., and Durand G. Dietary fish oil affects monoaminergic neurotransmission and behavior in rats. Nutr Neurosci (1998) 2512-2519
14. Champeil-Potokar G., Denis I., Goustard-Langelier B., Alessandri J., Guesnet P., and Lavialle M. Astrocytes in culture require docosahexaenoic acid to restore the n-3/n-6 polyunsaturated fatty acid balance in their membrane phospholipids. J Neurosci Res 75 (2004) 96-106
15. Conquer J., Tierney M., Zecevic J., Bettger W., and Fisher R. Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia and cognitive impairment. Lipids 35 (2000) 1305-1312
16. Corrigan F., Horrobin D., Skinner E., Besson J., and Cooper M. Abnormal content of n-6 and n-3 long-chain unsaturated fatty acids in the phosphoglycerides and cholesterol esters of parahippocampal cortex from Alzheimer's disease patients and its relationship to acetyl CoA content. Int J Biochem Cell Biol 30 (1998) 197-207
17. Costa D., Cracchiolo J., Bachstetter A., Hughes T., Bales K., Paul S., Mervis R., Arendash G., and Potter H. Enrichment improves cognition in AD mice by amyloid-related and unrelated mechanisms. Neurobiol Aging 28 (2007) 831-844
18. Cracchiolo J., Mori T., Nazian S., Tan J., Potter H., and Arendash G. Enhanced cognitive activity-Over and above social or physical activity-Is required to protect Alzheimer's mice against cognitive impairment, reduce Aβ deposition, and increase synaptic immunoreactivity. Neurobiol Learn Mem 88 (2007) 277-294
19. de Wilde M., Farkas E., Gerrits M., Kiliaan A., and Luiten P. The effects of n-3 polyunsaturated fatty acid-rich diets on cognitive and cerebrovascular parameters in chronic cerebral hypoperfusion. Brain Res 947 (2002) 166-173
20. Engelhart M., Geerling M., and Ruitenberg A. Diet and risk of dementia: Does fat matter?. The Rotterdam Study. Neurology 59 (2002) 1915-1921
21. Ethell D., Shippy D., Cao C., Cracchiolo J., Runfedlt M., Blake B., and Arendash G. Aβ-specific T-cells reverse cognitive decline and synaptic loss in Alzheimer's mice. Neurobiol Dis 23 (2006) 351-361
22. Folch J., Lees M., and Sloane S. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 226 (1957) 495-509
23. Freund-Levi Y., Eriksdotter-Jonhagen M., Cederholm T., Basun H., Faxen-Irving G., Garlind A., Vedin I., Vexxby B., Wahlund L., and Palmblad J. ω-3 Fatty acid treatment in 174 patients with mild to moderate Alzheimer disease: OmegAD study. Arch Neurol 63 (2006) 1402-1408
24. Gamoh S., Hashimoto M., Hossain S., and Msumura S. Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin Exp Pharmacol Physiol 28 (2001) 266-270
25. Gordon M., King D., Diamond D., Jantzen P., Boyett K., Hope C., Hatcher J., DiCarlo G., Gottschalk P., Morgan D., and Arendash G. Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 mice. Neurobiol Aging 22 (2001) 377-386
26. Green K., Martinez-Coria H., Khashji H., Hall E., Yurko-Mauro K., Ellis L., and LaFerla F. Dietary docosahexaenoic acid and docosapentaenoic acid ameliorate amyloid-β and tau pathology via a mechanism involving presenilin 1 levels. J Neurosci 27 (2007) 4385-4395
27. Hashimoto M., Hossain S., Shimada T., Sugioka K., Yamasaki H., Fujii Y., Ishibashi Y., Oka J., and Shido O. Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J Neurochem 81 (2002) 1084-1091
28. Hashimoto M., Tanabe Y., Fujii Y., Kikuta T., Shibata H., and Shido O. Chronic administration of docosahexaenoic acid ameliorates the impairment of spatial cognition learning ability in amyloid beta-infused rats. J Nutr 135 (2005) 549-555
29. Huang T., Zandi P., Tucker K., Fitzpatrick A., Kuller L., Fried L., Burke G., and Carlson M. Benefits of fatty fish on dementia risk are stronger for those without APOE ε4. Neurology 65 (2005) 1409-1414
30. Ikemoto A., Ohishi M., Sato Y., Hata N., Misawa Y., Fujii Y., and Okuyama H. Reversibility of n-3 fatty acid deficieny-induced alterations of learning behavior in the rat: level of n-6 fatty acids as another critical factor. J Lipid Res 42 (2001) 1655-1663
31. Jensen M., Skarsfeldt T., and Høy C. Correlation between level of (n-3) polyunsaturated fatty acids in brain phospholipids and learning ability in rats. A multiple generation study. Biochim Biophys Acta 1300 (1996) 203-209
32. Jensen M., Mottin M., Cracchiolo J., Leighty R., and Arendash G. Lifelong immunization with human β-amyloid (1-42) protects Alzheimer's transgenic mice against cognitive impairment throughout aging. Neuroscience 130 (2005) 667-684
33. Kalmijn S., Launer L., Ott A., Witteman J., Hofman A., and Breteler M. Dietary fat intake and risk of incident dementia in the Rotterdam Study. Ann Neurol 42 (1997) 776-782
34. Kalmijn S., Feskens E., Launer L., and Kromhout D. Polyunsaturated fatty acids, antioxidants and cognitive function in very old men. Am J Epidemiol 145 (1997) 33-41
35. Kalmijn S., van Boxtel M., Ocke M., Verschuren W., Dromhout D., and Launer L. Dietary intake of fatty acids and fish in relation to cognitive performance at middle age. Neurology 62 (2004) 275-280
36. Laurin D., Verreault R., Lindsay J., Dewailly E., and Holub B. Omega-3 fatty acids and risk of cognitive impairment and dementia. J Alzheimer Dis 5 (2003) 315-322
37. Leighty R., Nilsson L., Potter H., Costa D., Low M., Bales K., Paul S., and Arendash G. Use of multimetric stastical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition. Behav Brain Res 153 (2004) 107-121
38. Lepage G., and Roy C. Direct ransesterification of all classes of lipids in a one-step reaction. J Lipid Res 27 (1986) 114-120
39. Lim S., and Suzuki H. Intakes of dietary docosahexaenoic acid ethyl ester and egg phosphatidylcholine improves maze-learning ability in young and old mice. Nutr Neurosci (1999) 1629-1632
40. Lim S., and Suzuki H. Changes in maze behavior of mice occur after sufficient accumulation of docosahexaenoic acid in brain. Nutr Neurosci (2000) 319-324
41. Lim G., Calon F., Morihara T., Yang F., Teter B., Ubeda O., Salem N., Frautshy S., and Cole G. A diet enriched with omega-3 fatty acid docosahexaenoic acid reduces amyloid burden in an aged Alzheimer mouse model. J Neurosci 25 (2005) 3032-3040
42. Morris M., Evans D., Tangney C., Bienias J., and Wilson R. Fish consumption and cognitive decline with age in a large community study. Arch Neurol 62 (2005) 1-5
43. Nilsson L., Arendash G., Leighty R., Costa D., Low M., Garcia M., Cracchiolo J., Rojiani A., Wu X., Bales K., Paul S., and Potter H. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurbiol Aging 25 (2004) 1153-1167
44. Prasad M., Lovell M., Yatin M., Dhillon H., and Markesbery W. Regional membrane phospholipid alterations in Alzheimer's disease. Neurochem Res 23 (1998) 81-88
45. Puskas L., Kitajka K., Nyaka C., Barceló-Coblijn G., and Farkas T. Short-term administration of omega-3 fatty acids from fish oil results in increased transthyretin transcription in old rat hippocampus. Proc Natl Acad Sci U S A 100 (2003) 1580-1585
46. Rodondo C., Damas A., and Sariava M. Designing transthryetin mutants affecting tetrameric structure: Implications in amyloidogenicity. Biochem J 348 (2000) 167-172
47. Schaefer E., Bongard V., Beiser A., Lamon-Fava S., Robins S., Au R., Tucker K., Kyle D., Wilson P., and Wolf P. Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease. Arch Neurol 63 (2006) 1545-1550
48. Schwarzman A., and Goldgaber D. Interaction of transthyretin with amyloid beta-protein: Binding and inhibition of amyloid formation. Ciba Found Symp 199 (1996) 146-160
49. Skinner E., Watt C., Besson J., and Best P. Differences in the fatty acid composition of the grey and white matter of different regions of the brains of patients with Alzheimer's disease and control subjects. Brain 116 (1993) 717-725
50. Soderberg M., Edlund C., Kristensson K., and Dallner G. Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease. Lipids 26 (1991) 421-425
51. Sugimoto Y., Taga C., Nishiga M., Fujiwara M., Konishi F., Tanaka K., and Kamei C. Effect of docosahexaenoic acid-fortified Chlorella vulgaris strain CK22 on the radial maze performance in aged mice. Biol Pharm Bull 25 (2002) 1090-1092
52. Suh M., Wierzbicki A., Lien E., and Clandinin M. Dietary 20:4n-6 and 22:6n-3 modulates the profile of long- and very long-chair fatty acids, rhodopsin content, and kinetics in developing photoreceptor cells. Pediatr Res 48 (2000) 524-530
53. Suzuki H., Park S., Tamura M., and Ando S. Effect of the long-term feeding of dietary lipids on the learning ability, fatty acid composition of brain stem phospholipids and synaptic membrane fluidity in adult mice: A comparison of sardine oil diet and palm oil diet. Mech Aging Dev 101 (1998) 119-128
54. 1-42 and the risk of dementia: a prospective case-cohort study. Lancet Neurol 5 (2006) 655-660
55. von Gelder B., Tijhuis M., Kalmijn S., and Kromhout D. Fish consumption, n-3 fatty acids, and subsequent 5-y cognitive decline in elderly men: The Zutphen Elderly Study. Am J Clin Nutri 85 (2007) 1142-1147
56. Wainwright P., Xing H., Ward G., Huang Y., Bobik E., Auestad N., and Montalto M. Water maze performance is unaffected in artificially reared rats fed diets supplemented with arachidonic acid and docosahexaenoic acid. Nutr Neurosci (1999) 1079-1089
57. Ward G., Huang Y., Bobik E., Xing H.-C., Mutsaers L., Auestad N., Montalto M., and Wainwright P. Long-chain polyunsaturated fatty acid levels in formulae influence deposition of docosahexaenoic acid and arachidonic acid in brain and red blood cells of artificially reared neonatal rats. J Nutr 128 (1998) 2473-2487
58. Winocur G., and Greenwood C. Studies of the effects of high fat diets on cognitive function in a rat model. Neurobiol Aging 26 (2005) 46-49